103 related articles for article (PubMed ID: 1621201)
1. Short term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus.
Coddington CC; Brzyski R; Hansen KA; Corley DR; McIntyre-Seltman K; Jones HW
Surg Gynecol Obstet; 1992 Jul; 175(1):57-63. PubMed ID: 1621201
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
3. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
Cheviakoff S; Bocaz JA; Martínez L; Romero C
Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial.
Serra GB; Panetta V; Colosimo M; Romanini C; Lafuenti GB; Garcea N; Votano S; Agatensi L
Clin Ther; 1992; 14 Suppl A():57-73. PubMed ID: 1606594
[TBL] [Abstract][Full Text] [Related]
6. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ
Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
[TBL] [Abstract][Full Text] [Related]
7. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
9. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
10. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
[TBL] [Abstract][Full Text] [Related]
11. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.
Reinsch RC; Murphy AA; Morales AJ; Yen SS
Am J Obstet Gynecol; 1994 Jun; 170(6):1623-7; discussion 1627-8. PubMed ID: 8203418
[TBL] [Abstract][Full Text] [Related]
12. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
Hutchins FL
J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
[TBL] [Abstract][Full Text] [Related]
13. [Short-term therapy of uterine fibromyomatosis with GN-Rh analog].
Massacesi M; Milkowski M; Gianfranceschi C; Massacesi L
Minerva Ginecol; 1992 Dec; 44(12):641-4. PubMed ID: 1491772
[TBL] [Abstract][Full Text] [Related]
14. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
[TBL] [Abstract][Full Text] [Related]
15. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume.
Murphy NJ; Wallace DL
Gynecol Oncol; 1993 May; 49(2):266-7. PubMed ID: 8504999
[TBL] [Abstract][Full Text] [Related]
17. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
19. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
20. [Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period].
Russo P; Ciolli P; Atlante M; Carico E; Mancini R; Russo R; Vecchione A
Minerva Ginecol; 1998 Nov; 50(11):499-502. PubMed ID: 9882992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]